189330 — XIIlab Co Balance Sheet
0.000.00%
- KR₩45bn
- KR₩40bn
- KR₩9bn
Annual balance sheet for XIIlab Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,228 | 25,042 | 18,945 | 13,150 | 8,232 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,608 | 1,010 | 5,339 | 910 | 1,632 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,852 | 26,076 | 24,291 | 14,080 | 9,952 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,236 | 4,341 | 3,531 | 2,308 | 1,846 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 11,861 | 31,358 | 28,800 | 18,017 | 13,396 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,582 | 3,816 | 5,903 | 1,447 | 2,589 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 8,743 | 6,829 | 8,071 | 3,202 | 3,796 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,118 | 24,529 | 20,729 | 14,814 | 9,600 |
| Total Liabilities & Shareholders' Equity | 11,861 | 31,358 | 28,800 | 18,017 | 13,396 |
| Total Common Shares Outstanding |